Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool

被引:51
作者
Quintas, Guillermo [4 ]
Portillo, Nuria [3 ]
Carlos Garcia-Canaveras, Juan [1 ,2 ]
Vicente Castell, Jose [1 ,2 ]
Ferrer, Alberto [3 ]
Lahoz, Agustin [1 ]
机构
[1] Inst Invest Sanitaria Fdn Hosp La Fe, Unidad Hepatol Expt, Valencia 46009, Spain
[2] Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, Valencia, Spain
[3] Univ Politecn Valencia, Dept Appl Stat Operat Res & Qual, E-46071 Valencia, Spain
[4] Inst Invest Sanitaria Fdn Hosp La Fe, Unidad Analit Mixta, Valencia 46009, Spain
关键词
Metabolomics; Mass spectrometry; PLSDA and steatosis; SELECTION; SPECTROMETRY; REGRESSION; DISCRIMINATION; VALIDATION; NMR;
D O I
10.1007/s11306-011-0292-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An MS-based metabolomics strategy including variable selection and PLSDA analysis has been assessed as a tool to discriminate between non-steatotic and steatotic human liver profiles. Different chemometric approaches for uninformative variable elimination were performed by using two of the most common software packages employed in the field of metabolomics (i.e., MATLAB and SIMCA-P). The first considered approach was performed with MATLAB where the PLS regression vector coefficient values were used to classify variables as informative or not. The second approach was run under SIMCA-P, where variable selection was performed according to both the PLS regression vector coefficients and VIP scores. PLSDA models performance features, such as model validation, variable selection criteria, and potential biomarker output, were assessed for comparison purposes. One interesting finding is that variable selection improved the classification predictiveness of all the models by facilitating metabolite identification and providing enhanced insight into the metabolic information acquired by the UPLC-MS method. The results prove that the proposed strategy is a potentially straightforward approach to improve model performance. Among others, GSH, lysophospholipids and bile acids were found to be the most important altered metabolites in the metabolomic profiles studied. However, further research and more in-depth biochemical interpretations are needed to unambiguously propose them as disease biomarkers.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 41 条
[1]  
[Anonymous], 2009, CHEMOMETRICS PATTERN
[2]   Partial least squares for discrimination [J].
Barker, M ;
Rayens, W .
JOURNAL OF CHEMOMETRICS, 2003, 17 (03) :166-173
[3]   Liquid Chromatography-Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease [J].
Barr, Jonathan ;
Vazquez-Chantada, Mercedes ;
Alonso, Cristina ;
Perez-Cormenzana, Miriam ;
Mayo, Rebeca ;
Galan, Asier ;
Caballeria, Juan ;
Martin-Duce, Antonio ;
Tran, Albert ;
Wagner, Conrad ;
Luka, Zigmund ;
Lu, Shelly C. ;
Castro, Azucena ;
Le Marchand-Brustel, Yannick ;
Luz Martinez-Chantar, M. ;
Veyrie, Nicolas ;
Clement, Karine ;
Tordjman, Joan ;
Gual, Philippe ;
Mato, Jose M. .
JOURNAL OF PROTEOME RESEARCH, 2010, 9 (09) :4501-4512
[4]   Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation [J].
Bijlsma, S ;
Bobeldijk, L ;
Verheij, ER ;
Ramaker, R ;
Kochhar, S ;
Macdonald, IA ;
van Ommen, B ;
Smilde, AK .
ANALYTICAL CHEMISTRY, 2006, 78 (02) :567-574
[5]   Genetic algorithms for simultaneous variable and sample selection in metabonomics [J].
Cavill, Rachel ;
Keun, Hector C. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. ;
Ebbels, Timothy M. D. .
BIOINFORMATICS, 2009, 25 (01) :112-118
[6]   Recent advances in nonalcoholic fatty liver disease [J].
Cheung, Onpan ;
Sanyal, Arun J. .
CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (03) :230-237
[7]   Performance of some variable selection methods when multicollinearity is present [J].
Chong, IG ;
Jun, CH .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2005, 78 (1-2) :103-112
[8]   Exploring Mass Spectrometry Suitability to Examine Human Liver Graft Metabonomic Profiles [J].
Cortes, M. ;
Pareja, E. ;
Castell, J. V. ;
Moya, A. ;
Mir, J. ;
Lahoz, A. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) :2953-2958
[9]   Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models [J].
den Boer, M ;
Voshol, PJ ;
Kuipers, F ;
Havekes, LM ;
Romijn, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :644-649
[10]   Pathogenesis of non-alcoholic fatty liver disease [J].
Dowman, J. K. ;
Tomlinson, J. W. ;
Newsome, P. N. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (02) :71-83